Patents by Inventor Augusto Canavesi

Augusto Canavesi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sunitinib and salts thereof and their polymorphs
    Patent number: 9067915
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: June 30, 2015
    Assignee: Teva Pharmaceutical Industries LTD.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Sunitinib and salts thereof and their polymorphs
    Patent number: 8618309
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: December 31, 2013
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • SUNITINIB AND SALTS THEREOF AND THEIR POLYMORPHS
    Publication number: 20130296575
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Application
    Filed: July 17, 2013
    Publication date: November 7, 2013
    Inventors: Alexandr JEGOROV, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof
    Patent number: 8217061
    Abstract: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: July 10, 2012
    Assignee: Sicor Inc.
    Inventors: Ale{hacek over (s)} Gavenda, Alexandr Jegorov, Pierluigi Rossetto, Peter Lindsay MacDonald, Augusto Canavesi
  • SUNITINIB AND SALTS THEREOF AND THEIR POLYMORPHS
    Publication number: 20110118477
    Abstract: Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
    Type: Application
    Filed: July 23, 2009
    Publication date: May 19, 2011
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Alexandr Jegorov, Ales Gavenda, Pavel Vraspir, Augusto Canavesi, Francesca Scarpitta
  • PROCESS FOR THE PREPARATION OF N-PROTECTED-DECYLAMINOETHANAL
    Publication number: 20110009596
    Abstract: Compounds useful in the preparation of telavancin, for example, were prepared. These compounds include decylaminoethanal dialkyl acetals and N-protected decylaminoethanal dialkyl acetals, imidazolidine derivatives, and N-protected-decylaminoethanal.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Applicant: Plus Chemicals SA
    Inventors: Ettore Bigatti, Deborah Bollini, Augusto Canavesi, Ondrej Simo
  • POLYMORPHS OF SUNITINIB BASE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20100256392
    Abstract: The present invention provides polymorphs of Sunitinib base and processes for preparation thereof.
    Type: Application
    Filed: November 21, 2008
    Publication date: October 7, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Ales Gavenda, Ettore Bigatti, Alexandr Jegorov, Augusto Canavesi, Pavel Vraspir, Judith Aronhime, Peter Lindsay MacDonald, Francesca Scarpitta, Marco Villa, Paolo Angioletti
  • PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF
    Publication number: 20100160646
    Abstract: Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways.
    Type: Application
    Filed: March 4, 2010
    Publication date: June 24, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Ettore Bigatti, Augusto Canavesi, Peter Lindsay Macdonald, Francesca Scarpitta
  • CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL
    Publication number: 20100004449
    Abstract: The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
    Type: Application
    Filed: July 7, 2009
    Publication date: January 7, 2010
    Applicant: PLUS CHEMICALS SA
    Inventors: Ales GAVENDA, Pavel VRASPIR, Augusto CANAVESI, Judith ARONHIME, Ettore BIGATTI, Jiri FAUSTMANN, Alexandr JEGOROV, Peter W. STEPHENS, Giovanna LUX, Maurizio PAIOCCHI
  • Process for the preparation of sorafenib and salts thereof
    Publication number: 20090253913
    Abstract: Methods for the synthesis of the N-carbamoyl imidazole (I) and its 1:1 adduct with imidazole are provided. Methods for the preparation of these crystalline intermediates in a high state of purity are also provided. These intermediates react cleanly under mild conditions to produce sorafenib in high yield and purity, without generating difficult-to-remove impurities.
    Type: Application
    Filed: March 5, 2009
    Publication date: October 8, 2009
    Inventors: Pierluigi Rossetto, Peter Lindsay MacDonald, Augusto Canavesi
  • PROCESSES FOR PREPARING SUNITINIB AND SALTS THEREOF
    Publication number: 20090247767
    Abstract: Methods for preparing sunitinib or salts thereof are described using novel intermediates and chemical pathways.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 1, 2009
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Ettore BIGATTI, Augusto CANAVESI, Peter Lindsay MACDONALD, Francesca Scarpitta
  • POLYMORPHS OF SORAFENIB TOSYLATE AND SORAFENIB HEMI-TOSYLATE, AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20090192200
    Abstract: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 19, 2009
    Publication date: July 30, 2009
    Inventors: Ales Gavenda, Alexandr Jegorov, Pierluigi Rossetto, Peter Lindsay MacDonald, Augusto Canavesi
  • PROCESSES FOR PREPARING DARIFENACIN HYDROBROMIDE
    Publication number: 20090156831
    Abstract: The invention encompasses processes for the preparation of darifenacin hydrobromide.
    Type: Application
    Filed: February 19, 2009
    Publication date: June 18, 2009
    Inventors: Valeriano MERLI, Augusto CANAVESI, Paola DAVERIO
  • Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI
    Publication number: 20090131665
    Abstract: The invention provides processes for preparing crystalline Forms A, B and pure crystalline Form A of Erlotinib hydrochloride.
    Type: Application
    Filed: August 25, 2008
    Publication date: May 21, 2009
    Inventors: Ales Gavenda, Jiri Faustmann, Augusto Canavesi, Dietmar Flubacher
  • Crystalline forms of Erlotinib HCI and formulations thereof
    Publication number: 20090124642
    Abstract: The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof.
    Type: Application
    Filed: August 25, 2008
    Publication date: May 14, 2009
    Inventors: Augusto Canavesi, Marco Villa, Ales Gavenda, Jiri Faustmann, Judith Aronhime, Ettore Gibatti, Alexandr Jegorov
  • Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib
    Publication number: 20090012295
    Abstract: The present invention provides amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib.
    Type: Application
    Filed: June 25, 2008
    Publication date: January 8, 2009
    Inventors: Ales Gavenda, Augusto Canavesi, Dietmar Flubacher, Jiri Faustmann, Alexandr Jegorov
  • Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
    Publication number: 20080269504
    Abstract: Provided are darifenacin hydrobromide free of oxidized darifenacin, and processes for the preparation thereof.
    Type: Application
    Filed: July 1, 2008
    Publication date: October 30, 2008
    Inventors: Valeriano Merli, Augusto Canavesi, Paola Daverio, Alessandra Vailati
  • Processes for preparing darifenacin hydrobromide
    Publication number: 20080269505
    Abstract: The invention encompasses processes for the preparation of darifenacin hydrobromide.
    Type: Application
    Filed: July 1, 2008
    Publication date: October 30, 2008
    Inventors: Valeriano Merli, Augusto Canavesi, Paola Daverio
  • Processes for preparing darifenacin hydrobromide
    Publication number: 20080269503
    Abstract: The invention encompasses processes for the preparation of darifenacin hydrobromide.
    Type: Application
    Filed: July 1, 2008
    Publication date: October 30, 2008
    Inventors: Valeriano Merli, Augusto Canavesi, Paola Daverio
  • Processes for preparing darifenacin hydrobromide
    Patent number: 7442806
    Abstract: The invention encompasses processes for the preparation of darifenacin hydrobromide.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: October 28, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Valeriano Merli, Augusto Canavesi, Paola Daverio